Patient experience and satisfaction with Onabotulinumtoxin A for refractory overactive bladder

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|3|443-449

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.3, 2015-09, pp. : 443-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of onabotulinumtoxinA injection in patients with refractory overactive bladder: First multicentric study in Turkish population

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 263-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder

By Bolge Susan C.   McDonnell Diana D.   Chen Andrew   Wan George J.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1903-1912

Informa Healthcare

Access to resources Recommend Favorite

Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti‐muscarinic treatment

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 6, 2015-06 ,pp. : 957-961

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient experience with darifenacin – results of a short-term community-based survey in managing overactive bladder

By Green Lonny   Kerney Donna  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 431-437

Informa Healthcare

Access to resources Recommend Favorite

Botulinum toxin (OnabotulinumtoxinA) in the male non‐neurogenic overactive bladder: clinical and quality of life outcomes

By  

BJU INTERNATIONAL, Vol. 116, Iss. S3, 2015-10 ,pp. : 61-65

John Wiley & Sons Inc

Access to resources Recommend Favorite